{"id":16895,"date":"2025-12-12T10:32:12","date_gmt":"2025-12-12T10:32:12","guid":{"rendered":"https:\/\/www.quantumrun.com\/consulting\/?p=16895"},"modified":"2026-11-10T09:32:32","modified_gmt":"2026-11-10T09:32:32","slug":"molbert-statistics","status":"publish","type":"post","link":"https:\/\/www.quantumrun.com\/consulting\/molbert-statistics\/","title":{"rendered":"MolBERT Statistics And User Trends 2026"},"content":{"rendered":"\n<style>\n@import url('https:\/\/fonts.googleapis.com\/css2?family=Source+Serif+4:wght@400;600;700&family=DM+Sans:wght@400;500;600&display=swap');\n\n.molbert-article p {\n    margin-bottom: 18px;\n    font-size: 17px;\n}\n\n.molbert-article h2 {\n    font-family: 'Source Serif 4', serif;\n    font-size: 28px;\n    font-weight: 700;\n    margin: 40px 0 20px;\n    color: #0d1b2a;\n    border-bottom: 2px solid #e8e8e8;\n    padding-bottom: 10px;\n}\n\n.molbert-article h3 {\n    font-family: 'Source Serif 4', serif;\n    font-size: 21px;\n    font-weight: 600;\n    margin: 30px 0 15px;\n    color: #1b263b;\n}\n\n.molbert-article ul {\n    margin: 20px 0;\n    padding-left: 0;\n    list-style: none;\n}\n\n.molbert-article ul li {\n    padding: 12px 0 12px 24px;\n    border-left: 3px solid #415a77;\n    margin-bottom: 10px;\n    background: #fafafa;\n    font-size: 16px;\n}\n\n.molbert-article table {\n    width: 100%;\n    border-collapse: collapse;\n    margin: 25px 0;\n    font-size: 15px;\n}\n\n.molbert-article th {\n    background: #1b263b;\n    color: #fff;\n    padding: 14px 12px;\n    text-align: center;\n    font-weight: 600;\n}\n\n.molbert-article td {\n    padding: 12px;\n    text-align: center;\n    border-bottom: 1px solid #e0e0e0;\n}\n\n.molbert-article tr:hover {\n    background: #f8f9fa;\n}\n\n.chart-container {\n    margin: 30px 0;\n    padding: 20px;\n    background: #fff;\n    border: 1px solid #e8e8e8;\n    border-radius: 8px;\n   height: 500px;\n    display: flex;\n    justify-content: center;\n    align-items: center;\n}\n\n.molbert-article details {\n    margin-bottom: 12px;\n    border: 1px solid #e0e0e0;\n    border-radius: 6px;\n    overflow: hidden;\n}\n\n.molbert-article summary {\n    padding: 16px 20px;\n    cursor: pointer;\n    font-weight: 500;\n    background: #fafafa;\n    transition: background 0.2s ease;\n    list-style: none;\n    display: flex;\n    justify-content: space-between;\n    align-items: center;\n}\n\n.molbert-article summary::-webkit-details-marker {\n    display: none;\n}\n\n.molbert-article summary::after {\n    content: '+';\n    font-size: 20px;\n    font-weight: 400;\n    color: #415a77;\n}\n\n.molbert-article details[open] summary::after {\n    content: '-';\n}\n\n.molbert-article summary:hover {\n    background: #f0f0f0;\n}\n\n.molbert-article details p {\n    padding: 16px 20px;\n    margin: 0;\n    background: #fff;\n    font-size: 15px;\n}\n\n.citations {\n    margin-top: 40px;\n    padding-top: 20px;\n    border-top: 1px solid #e0e0e0;\n    font-size: 14px;\n    color: #555;\n}\n\n.citations a {\n    color: #415a77;\n    text-decoration: none;\n}\n\n.citations a:hover {\n    text-decoration: underline;\n}\n<\/style>\n\n<script src=\"https:\/\/cdn.jsdelivr.net\/npm\/chart.js\"><\/script>\n\n<div class=\"molbert-article\">\n\n<p>MolBERT has processed approximately 1.6 million SMILES molecular strings through its pre-training corpus, establishing itself as a leading transformer-based model for computational drug discovery. The model achieved superior performance on 45 of 69 virtual screening benchmark targets as of 2025. Operating within an AI drug discovery market valued at $6.31 billion in 2024, MolBERT represents a significant advancement in applying natural language processing architectures to molecular property prediction.<\/p>\n\n<h2>MolBERT Key Statistics<\/h2>\n\n<ul>\n    <li>MolBERT pre-training corpus contains approximately 1.6 million SMILES strings as of 2025<\/li>\n    <li>The combined ZINC 15 and ChEMBL 27 dataset provides 4 million compounds for Mol-BERT training<\/li>\n    <li>MolBERT achieves superior virtual screening performance on 45 of 69 benchmark targets<\/li>\n    <li>NABP-BERT variant records 0.986 AUROC for nanobody-antigen binding prediction<\/li>\n    <li>AI drug discovery market reached $6.31 billion in 2024 with 10.10% projected CAGR through 2034<\/li>\n<\/ul>\n\n<h2>MolBERT Pre-Training Dataset Statistics<\/h2>\n\n<p>MolBERT leverages large-scale unsupervised pre-training on molecular data to learn generalizable representations. The model utilizes 200 RDKit physicochemical descriptors and filters compounds within a molecular weight range of 12-600 Da.<\/p>\n\n<table>\n    <tbody><tr>\n        <th>Parameter<\/th>\n        <th>Value<\/th>\n    <\/tr>\n    <tr>\n        <td>SMILES Strings in Pre-Training Corpus<\/td>\n        <td>~1.6 Million<\/td>\n    <\/tr>\n    <tr>\n        <td>Total Compounds (ZINC 15 + ChEMBL 27)<\/td>\n        <td>4 Million<\/td>\n    <\/tr>\n    <tr>\n        <td>Physicochemical Descriptors<\/td>\n        <td>200<\/td>\n    <\/tr>\n    <tr>\n        <td>Embedding Dimension<\/td>\n        <td>764<\/td>\n    <\/tr>\n    <tr>\n        <td>Heavy-Atom Count Range<\/td>\n        <td>3-50 Atoms<\/td>\n    <\/tr>\n<\/tbody><\/table>\n\n<p>The pre-training approach employs three self-supervised tasks: Masked Language Modeling, SMILES Equivalence, and Physicochemical Property Prediction. Research indicates PhysChemPred has substantial influence on model performance across QSAR and virtual screening benchmarks.<\/p>\n\n<h2>MolBERT Benchmark Performance<\/h2>\n\n<p>MolBERT has been evaluated against multiple established benchmarks for molecular property prediction. The model demonstrates particular strength in virtual screening tasks and classification problems involving molecular activity prediction.<\/p>\n\n<div class=\"chart-container\">\n    <canvas id=\"benchmarkChart\"><\/canvas>\n<\/div>\n\n<p>BERT-based models achieve nearly twofold improvement in sample acquisition efficiency compared to conventional ECFP-based approaches. In active learning scenarios for ClinTox, MolBERT required approximately 100 iterations versus 180 iterations for ECFP to extract 70% positive samples.<\/p>\n\n<h3>MoleculeNet Dataset Composition<\/h3>\n\n<p>MoleculeNet serves as the primary benchmarking framework for evaluating MolBERT. The benchmark encompasses datasets spanning quantum mechanics, physical chemistry, biophysics, and physiology domains with approximately 600,000 total compounds.<\/p>\n\n<div class=\"chart-container\">\n    <canvas id=\"moleculenetChart\"><\/canvas>\n<\/div>\n\n<h2>AI Drug Discovery Market Growth<\/h2>\n\n<p>MolBERT operates within a rapidly expanding market for AI-driven drug discovery. The global market recorded $6.31 billion in 2024 and is projected to reach $16.52 billion by 2034, according to Precedence Research.<\/p>\n\n<div class=\"chart-container\">\n    <canvas id=\"marketChart\"><\/canvas>\n<\/div>\n\n<p>North America held 56.18% market share in 2024, with the U.S. market alone valued at $2.61 billion. Machine learning technologies account for 66% of market applications. Survey data from the 2024 American Society of Clinical Pharmacology and Therapeutics meeting revealed 80% of participants recognize AI&#8217;s significant impact on drug research.<\/p>\n\n<h2>MolBERT Architecture Specifications<\/h2>\n\n<p>MolBERT&#8217;s architecture builds upon the established BERT framework, adapting transformer-based self-attention mechanisms for molecular representation learning. Research findings indicate shallow networks with single encoder layers prove sufficient for molecular binding prediction.<\/p>\n\n<table>\n    <tbody><tr>\n        <th>Component<\/th>\n        <th>Specification<\/th>\n    <\/tr>\n    <tr>\n        <td>Base Architecture<\/td>\n        <td>Transformer (BERT-based)<\/td>\n    <\/tr>\n    <tr>\n        <td>Optimal Attention Heads<\/td>\n        <td>8<\/td>\n    <\/tr>\n    <tr>\n        <td>Hidden Size<\/td>\n        <td>768<\/td>\n    <\/tr>\n    <tr>\n        <td>Optimal Encoder Layers<\/td>\n        <td>1 (Shallow Network)<\/td>\n    <\/tr>\n    <tr>\n        <td>Pre-Training Objectives<\/td>\n        <td>3<\/td>\n    <\/tr>\n<\/tbody><\/table>\n\n<p>Performance evaluation across varying encoder depths shows AUROC decreases from 0.986 to 0.921 as encoder layers increase from 1 to 12, suggesting excessive model depth does not improve molecular property prediction accuracy.<\/p>\n\n<h2>MolBERT Investment and Development Trends<\/h2>\n\n<p>The AI drug discovery ecosystem has attracted substantial funding in 2024-2025. Xaira Therapeutics launched with over $1 billion in funding in April 2024. Pfizer and PostEra established a $610 million partnership framework in January 2025. Total investment in AI research and development<\/a> for drug discovery exceeded $100 billion over the past five years.<\/p>\n\n<div class=\"chart-container\">\n    <canvas id=\"investmentChart\"><\/canvas>\n<\/div>\n\n<p>The 2024 Nobel Prize in Chemistry awarded to David Baker, Demis Hassabis, and John Jumper for AI-based protein structure prediction validated transformer-based approaches in life sciences.<\/p>\n\n<h2>FAQ<\/h2>\n\n<details>\n    <summary>How many SMILES strings does MolBERT use for pre-training?<\/summary>\n    <p>MolBERT&#8217;s pre-training corpus contains approximately 1.6 million SMILES strings sourced from established chemical databases including ZINC 15 and ChEMBL 27.<\/p>\n<\/details>\n\n<details>\n    <summary>What is MolBERT&#8217;s benchmark performance rate?<\/summary>\n    <p>MolBERT achieves superior virtual screening performance on 45 of 69 benchmark targets, with NABP-BERT variant recording 0.986 AUROC for binding prediction tasks.<\/p>\n<\/details>\n\n<details>\n    <summary>How large is the AI drug discovery market?<\/summary>\n    <p>The global AI drug discovery market reached $6.31 billion in 2024 and is projected to grow to $16.52 billion by 2034 at a 10.10% CAGR.<\/p>\n<\/details>\n\n<details>\n    <summary>What architecture does MolBERT use?<\/summary>\n    <p>MolBERT uses a transformer-based BERT architecture with 8 attention heads, 768 hidden size, and optimal performance at 1 encoder layer for molecular binding prediction.<\/p>\n<\/details>\n\n<details>\n    <summary>What datasets are used to evaluate MolBERT?<\/summary>\n    <p>MolBERT is evaluated on MoleculeNet benchmarks including BACE, BBBP, HIV, ESOL, FreeSolv, and Lipophilicity datasets spanning approximately 600,000 compounds.<\/p>\n<\/details>\n\n<div class=\"citations\">\n    <p><strong>Sources:<\/strong><\/p>\n    <p><a href=\"https:\/\/www.nature.com\/articles\/s41467-024-45102-8\" rel=\"nofollow\">Nature Communications &#8211; MolBERT Research<\/a><\/p>\n    <p><a href=\"https:\/\/www.precedenceresearch.com\/ai-in-drug-discovery-market\" rel=\"nofollow\" class=\"external\">Precedence Research &#8211; AI Drug Discovery Market Report<\/a><\/p>\n    <p><a href=\"https:\/\/academic.oup.com\/nar\/article\/52\/D1\/D1180\/7416387\" rel=\"nofollow\" class=\"external\">Nucleic Acids Research &#8211; ChEMBL Database<\/a><\/p>\n    <p><a href=\"https:\/\/jcheminf.biomedcentral.com\/articles\/10.1186\/s13321-024-00832-x\" rel=\"nofollow\" class=\"external\">Journal of Cheminformatics &#8211; Molecular Benchmarks<\/a><\/p>\n<\/div>\n\n<\/div>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>MolBERT has processed approximately 1.6 million SMILES molecular strings through its pre-training corpus, establishing itself as a leading transformer-based model for computational drug discovery. The model achieved superior performance on 45 of 69 virtual screening benchmark targets as of 2025. Operating within an AI drug discovery market valued at $6.31 billion in 2024, MolBERT represents [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":16897,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[130],"tags":[],"class_list":["post-16895","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ai"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>MolBERT Statistics And User Trends 2026<\/title>\n<meta name=\"description\" content=\"MolBERT has processed approximately 1.6 million SMILES molecular strings through its pre-training corpus, establishing itself as a leading\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.quantumrun.com\/consulting\/molbert-statistics\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MolBERT Statistics And User Trends 2026\" \/>\n<meta property=\"og:description\" content=\"MolBERT has processed approximately 1.6 million SMILES molecular strings through its pre-training corpus, establishing itself as a leading\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.quantumrun.com\/consulting\/molbert-statistics\/\" \/>\n<meta property=\"og:site_name\" content=\"Quantumrun Foresight\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-12T10:32:12+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-10T09:32:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.quantumrun.com\/consulting\/wp-content\/uploads\/2025\/12\/MolBERT-Statistics-And-User-Trends-2026-e1765535496841.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"945\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Richard Jaimes\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Richard Jaimes\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/molbert-statistics\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/molbert-statistics\\\/\"},\"author\":{\"name\":\"Richard Jaimes\",\"@id\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/#\\\/schema\\\/person\\\/5a0afcb410d8e3137f58d5a201809011\"},\"headline\":\"MolBERT Statistics And User Trends 2026\",\"datePublished\":\"2025-12-12T10:32:12+00:00\",\"dateModified\":\"2026-11-10T09:32:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/molbert-statistics\\\/\"},\"wordCount\":698,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/molbert-statistics\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/MolBERT-Statistics-And-User-Trends-2026-e1765535496841.png\",\"articleSection\":[\"AI\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/molbert-statistics\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/molbert-statistics\\\/\",\"url\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/molbert-statistics\\\/\",\"name\":\"MolBERT Statistics And User Trends 2026\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/molbert-statistics\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/molbert-statistics\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/MolBERT-Statistics-And-User-Trends-2026-e1765535496841.png\",\"datePublished\":\"2025-12-12T10:32:12+00:00\",\"dateModified\":\"2026-11-10T09:32:32+00:00\",\"description\":\"MolBERT has processed approximately 1.6 million SMILES molecular strings through its pre-training corpus, establishing itself as a leading\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/molbert-statistics\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/molbert-statistics\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/molbert-statistics\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/MolBERT-Statistics-And-User-Trends-2026-e1765535496841.png\",\"contentUrl\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/MolBERT-Statistics-And-User-Trends-2026-e1765535496841.png\",\"width\":1024,\"height\":945,\"caption\":\"MolBERT transformer model processing 1.6 million SMILES molecular strings for AI drug discovery within a $6.31 billion market.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/molbert-statistics\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AI\",\"item\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/ai\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"MolBERT Statistics And User Trends 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/#website\",\"url\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/\",\"name\":\"Quantumrun Foresight\",\"description\":\"Thrive from future trends.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/#organization\",\"name\":\"Quantumrun Foresight\",\"url\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/wp-content\\\/uploads\\\/2020\\\/07\\\/cropped-con-logo-00.png\",\"contentUrl\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/wp-content\\\/uploads\\\/2020\\\/07\\\/cropped-con-logo-00.png\",\"width\":286,\"height\":55,\"caption\":\"Quantumrun Foresight\"},\"image\":{\"@id\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/#\\\/schema\\\/person\\\/5a0afcb410d8e3137f58d5a201809011\",\"name\":\"Richard Jaimes\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/552ad8a69a374ceb309e1045d345be2d8c30e8a0e8cda42acb1fc357ca381509?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/552ad8a69a374ceb309e1045d345be2d8c30e8a0e8cda42acb1fc357ca381509?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/552ad8a69a374ceb309e1045d345be2d8c30e8a0e8cda42acb1fc357ca381509?s=96&d=mm&r=g\",\"caption\":\"Richard Jaimes\"},\"sameAs\":[\"https:\\\/\\\/www.quantumrun.com\\\/consulting\"],\"url\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/author\\\/admin-stcons\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MolBERT Statistics And User Trends 2026","description":"MolBERT has processed approximately 1.6 million SMILES molecular strings through its pre-training corpus, establishing itself as a leading","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.quantumrun.com\/consulting\/molbert-statistics\/","og_locale":"en_US","og_type":"article","og_title":"MolBERT Statistics And User Trends 2026","og_description":"MolBERT has processed approximately 1.6 million SMILES molecular strings through its pre-training corpus, establishing itself as a leading","og_url":"https:\/\/www.quantumrun.com\/consulting\/molbert-statistics\/","og_site_name":"Quantumrun Foresight","article_published_time":"2025-12-12T10:32:12+00:00","article_modified_time":"2026-11-10T09:32:32+00:00","og_image":[{"width":1024,"height":945,"url":"https:\/\/www.quantumrun.com\/consulting\/wp-content\/uploads\/2025\/12\/MolBERT-Statistics-And-User-Trends-2026-e1765535496841.png","type":"image\/png"}],"author":"Richard Jaimes","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Richard Jaimes","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.quantumrun.com\/consulting\/molbert-statistics\/#article","isPartOf":{"@id":"https:\/\/www.quantumrun.com\/consulting\/molbert-statistics\/"},"author":{"name":"Richard Jaimes","@id":"https:\/\/www.quantumrun.com\/consulting\/#\/schema\/person\/5a0afcb410d8e3137f58d5a201809011"},"headline":"MolBERT Statistics And User Trends 2026","datePublished":"2025-12-12T10:32:12+00:00","dateModified":"2026-11-10T09:32:32+00:00","mainEntityOfPage":{"@id":"https:\/\/www.quantumrun.com\/consulting\/molbert-statistics\/"},"wordCount":698,"commentCount":0,"publisher":{"@id":"https:\/\/www.quantumrun.com\/consulting\/#organization"},"image":{"@id":"https:\/\/www.quantumrun.com\/consulting\/molbert-statistics\/#primaryimage"},"thumbnailUrl":"https:\/\/www.quantumrun.com\/consulting\/wp-content\/uploads\/2025\/12\/MolBERT-Statistics-And-User-Trends-2026-e1765535496841.png","articleSection":["AI"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.quantumrun.com\/consulting\/molbert-statistics\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.quantumrun.com\/consulting\/molbert-statistics\/","url":"https:\/\/www.quantumrun.com\/consulting\/molbert-statistics\/","name":"MolBERT Statistics And User Trends 2026","isPartOf":{"@id":"https:\/\/www.quantumrun.com\/consulting\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.quantumrun.com\/consulting\/molbert-statistics\/#primaryimage"},"image":{"@id":"https:\/\/www.quantumrun.com\/consulting\/molbert-statistics\/#primaryimage"},"thumbnailUrl":"https:\/\/www.quantumrun.com\/consulting\/wp-content\/uploads\/2025\/12\/MolBERT-Statistics-And-User-Trends-2026-e1765535496841.png","datePublished":"2025-12-12T10:32:12+00:00","dateModified":"2026-11-10T09:32:32+00:00","description":"MolBERT has processed approximately 1.6 million SMILES molecular strings through its pre-training corpus, establishing itself as a leading","breadcrumb":{"@id":"https:\/\/www.quantumrun.com\/consulting\/molbert-statistics\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.quantumrun.com\/consulting\/molbert-statistics\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.quantumrun.com\/consulting\/molbert-statistics\/#primaryimage","url":"https:\/\/www.quantumrun.com\/consulting\/wp-content\/uploads\/2025\/12\/MolBERT-Statistics-And-User-Trends-2026-e1765535496841.png","contentUrl":"https:\/\/www.quantumrun.com\/consulting\/wp-content\/uploads\/2025\/12\/MolBERT-Statistics-And-User-Trends-2026-e1765535496841.png","width":1024,"height":945,"caption":"MolBERT transformer model processing 1.6 million SMILES molecular strings for AI drug discovery within a $6.31 billion market."},{"@type":"BreadcrumbList","@id":"https:\/\/www.quantumrun.com\/consulting\/molbert-statistics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.quantumrun.com\/consulting\/"},{"@type":"ListItem","position":2,"name":"AI","item":"https:\/\/www.quantumrun.com\/consulting\/ai\/"},{"@type":"ListItem","position":3,"name":"MolBERT Statistics And User Trends 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.quantumrun.com\/consulting\/#website","url":"https:\/\/www.quantumrun.com\/consulting\/","name":"Quantumrun Foresight","description":"Thrive from future trends.","publisher":{"@id":"https:\/\/www.quantumrun.com\/consulting\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.quantumrun.com\/consulting\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.quantumrun.com\/consulting\/#organization","name":"Quantumrun Foresight","url":"https:\/\/www.quantumrun.com\/consulting\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.quantumrun.com\/consulting\/#\/schema\/logo\/image\/","url":"https:\/\/www.quantumrun.com\/consulting\/wp-content\/uploads\/2020\/07\/cropped-con-logo-00.png","contentUrl":"https:\/\/www.quantumrun.com\/consulting\/wp-content\/uploads\/2020\/07\/cropped-con-logo-00.png","width":286,"height":55,"caption":"Quantumrun Foresight"},"image":{"@id":"https:\/\/www.quantumrun.com\/consulting\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.quantumrun.com\/consulting\/#\/schema\/person\/5a0afcb410d8e3137f58d5a201809011","name":"Richard Jaimes","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/552ad8a69a374ceb309e1045d345be2d8c30e8a0e8cda42acb1fc357ca381509?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/552ad8a69a374ceb309e1045d345be2d8c30e8a0e8cda42acb1fc357ca381509?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/552ad8a69a374ceb309e1045d345be2d8c30e8a0e8cda42acb1fc357ca381509?s=96&d=mm&r=g","caption":"Richard Jaimes"},"sameAs":["https:\/\/www.quantumrun.com\/consulting"],"url":"https:\/\/www.quantumrun.com\/consulting\/author\/admin-stcons\/"}]}},"_links":{"self":[{"href":"https:\/\/www.quantumrun.com\/consulting\/wp-json\/wp\/v2\/posts\/16895","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.quantumrun.com\/consulting\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.quantumrun.com\/consulting\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.quantumrun.com\/consulting\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.quantumrun.com\/consulting\/wp-json\/wp\/v2\/comments?post=16895"}],"version-history":[{"count":3,"href":"https:\/\/www.quantumrun.com\/consulting\/wp-json\/wp\/v2\/posts\/16895\/revisions"}],"predecessor-version":[{"id":28393,"href":"https:\/\/www.quantumrun.com\/consulting\/wp-json\/wp\/v2\/posts\/16895\/revisions\/28393"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.quantumrun.com\/consulting\/wp-json\/wp\/v2\/media\/16897"}],"wp:attachment":[{"href":"https:\/\/www.quantumrun.com\/consulting\/wp-json\/wp\/v2\/media?parent=16895"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.quantumrun.com\/consulting\/wp-json\/wp\/v2\/categories?post=16895"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.quantumrun.com\/consulting\/wp-json\/wp\/v2\/tags?post=16895"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}